Tarsus Pharmaceuticals Inc
NASDAQ:TARS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
|
US |
|
Auxly Cannabis Group Inc
TSX:XLY
|
CA |
|
MT Educare Ltd
NSE:MTEDUCARE
|
IN |
|
Koninklijke DSM NV
AEX:DSM
|
NL |
|
O
|
Optimi Health Corp
CNSX:OPTI
|
CA |
|
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
|
TR |
|
TCPL Packaging Ltd
NSE:TCPLPACK
|
IN |
|
P
|
Poona Dal and Oil Industries Ltd
BSE:519359
|
IN |
Wall Street
Price Targets
TARS Price Targets Summary
Tarsus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
TARS
is 93.2 USD
with a low forecast of 85.85 USD and a high forecast of 105 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TARS's stock price target?
Price Target
93.2
USD
According to Wall Street analysts, the average 1-year price target for
TARS
is 93.2 USD
with a low forecast of 85.85 USD and a high forecast of 105 USD.
What is Tarsus Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
34%
The
compound annual growth rate
of Tarsus Pharmaceuticals Inc's revenue for the next 3 years is
34%.
